Skip to main content

Right-sided ureteral hemangiosarcoma in a paraplegic dog

Abstract

Background

This study aims to describe a rare case of primary ureteral hemangiosarcoma, in which surgical intervention preserved the kidney and ureter after tumor removal.

Case presentation

A 13-year-old, neutered male dog, weighing 14 kg, mixed-breed, presented with apathy, anorexia, acute-onset vomiting, and abdominal discomfort during the physical examination. Ultrasonography and pyelography revealed a right-sided dilation of the renal pelvis and ureter due to complete obstruction in the middle third of the ureter. A mass obstructing the lumen of the right ureter was completely resected, and ureteral suturing was performed, preserving the integrity of the involved structures. Histopathology confirmed primary ureteral hemangiosarcoma. Due to the local and non-invasive nature of the mass, chemotherapy was not initiated. The patient’s survival was approximately two years, and normal renal function was preserved throughout this period.

Conclusions

Considering this type of tumor in the differential diagnosis of upper urinary tract obstructive disorders. Furthermore, the preservation of the ureter and kidney is a suitable therapeutic option after surgical resection of non-invasive tumors.

Peer Review reports

Background

Hemangiosarcoma is a rapidly growing and aggressive malignant neoplasm, demonstrating significant metastatic potential due to its vascular association [1]. In dogs, the primary site of development is typically the spleen, followed by other locations such as subcutaneous tissue, dermis, liver, and right atrium [2,3,4,5]. Less common sites include the retroperitoneum, reproductive system, lung, and urinary system [6,7,8,9].

Primary neoplasms in the ureteral region are rare in dogs, and most often benign, including fibropapillomas, fibroepithelial polyps, and transitional cell papillomas [10,11,12]. Limited reports in dogs describe the occurrence of malignant neoplasms in this region, such as leiomyosarcomas [13, 14] and transitional cell carcinomas [15]. Even more rarely, only two cases of ureteral hemangiosarcoma have been reported to date [16, 17]. Given the rarity of this presentation, this report aims to provide detailed insights into the occurrence of ureteral hemangiosarcoma in an elderly dog, encompassing clinical and pathological manifestations, surgical treatment, diagnosis, and survival. This contributes evidence to the literature, emphasizing the importance of considering this type of tumor in the differential diagnosis of upper urinary tract disorders. To the best of our knowledge, this is the third reported case of primary ureteral hemangiosarcoma and the first to preserve the ureter and kidney without subsequent recurrence.

Case report

A male mixed-breed dog, 13 years old, weighing 14 kg, neutered, with a history of paraplegia due to an old traumatic injury (occurring when the animal was a puppy), presented with acute onset apathy, hematuria, anorexia, and vomiting. Due to the animal’s neurological condition, the dog’s urination history involved the need for manual bladder compressions throughout the day to achieve minimally acceptable bladder emptying, performed by its owner since the onset of its paraplegic condition. The patient also had a history of recurrent urinary tract infections due to chronic neurological bladder dysfunction. Pronounced abdominal discomfort was noted upon physical examination. Laboratory findings revealed mild azotemia in the serum biochemistry (urea 84 mg/dL and creatinine 2.0 mg/dL), with no other abnormalities in either biochemical analyses or the complete blood count.

Ultrasonographic examination disclosed hydronephrosis in the right kidney and hydroureter extending to the middle third, originating from a likely point of obstruction; however, the reason possibly associated with the obstruction was not determined by this evaluation. A pyelogram was performed to delineate the involved structures and precisely identify the obstructive site for surgical planning. The contrast examination consisted of the percutaneous administration of iodinated contrast, at a dose of 600 mg/kg, directly into the right renal pelvis with the assistance of ultrasound (the volume of contrast applied was equivalent to the volume removed by pyelocentesis). This confirmed a complete obstruction in the middle third of the right ureter, with no contrast progression beyond the identified point (Fig. 1).

Fig. 1
figure 1

Ultrasound-guided percutaneous anterograde pyelography, in lateral (A) and ventrodorsal (B) projections. Radiographs were obtained immediately after injection of iodinated contrast, noting dilation of the right renal pelvis and ureter, obstruction of the contrast column in the middle third of the right ureter, as well as deviation of the bony axis of the lumbar spine, luxation of L3-L4, L5-L6, bone remodeling of L6 and articular processes of L3 and L4, due to a history of old trauma. Radiographic images were obtained after the administration of iodinated contrast at a dose of 600 mg/kg

After laparotomy, the right ureter was identified, isolating the previously revealed obstruction point from the imaging examination (Fig. 2A). A longitudinal incision was made at the affected site, revealing tissue content causing obliteration of the ureteral lumen (Fig. 2B). The mass was fully exposed, demonstrating weak adhesion to the ventral wall of the ureter only in a small portion (approximately 0.5 mm) (Fig. 2C), and subsequently easily resected and removed from the ureteral lumen, along with the small portion of the involved ureter (Fig. 2D). The absence of neoformations in other regions of the urinary tract, as well as in abdominal organs, suggested a possible primary ureteral neoplasm. The ureteral incision was sutured using simple interrupted sutures with absorbable suture (poliglecaprone 25, 6 − 0), preserving the patient’s upper urinary tract, followed by routine closure of the abdominal cavity. The surgery was completed in 1 h and 40 min.

There were no complications during the surgical/anesthetic procedure, and the animal was discharged with follow-up care.

Fig. 2
figure 2

Surgical Procedure. A) Identification of the affected ureter and isolation of the obstruction site (region between the surgeon’s fingers). B) Longitudinal incision of the ureter and appearance of the tissue obliterating the lumen. C) Dissection and exposure of the mass within the ureter lumen. D) Final appearance of the mass after complete removal. Only one mass was found and removed (fragmentation of the mass occurred after its manipulation)

The histopathological examination of the mass confirmed the neoplastic nature of the removed tissue (Fig. 3), revealing a neoplastic proliferation composed of endothelial cells, mimicking disorganized vascular formations. Elongated cells with pleomorphic nuclei and prominent nucleoli, mild mitotic activity, and extensive areas of necrosis and hemorrhage were observed upon evaluation. On the surface of the mass, well-differentiated urothelial epithelium composed of 3 to 6 layers of cells was present. Based on these characteristics, the final diagnosis was consistent with ureteral hemangiosarcoma.

Fig. 3
figure 3

Histopathological Findings. A) Fragment lined by well-differentiated urothelial epithelium (EP). Submucosa (SM) with diffuse malignant mesenchymal neoplasia. Hematoxylin and Eosin (HE) staining. Magnification 200x. B) Neoplastic cells with solid and diffuse organization. HE staining. Magnification 400x. C) Mitotic figure, cell in metaphase (arrow). HE staining. Magnification 1,000x. D) Malignant mesenchymal proliferation with the formation of irregular vascular spaces filled with erythrocytes. Neoplastic cells exhibit pleomorphic nuclei with vesicular appearance and prominent nucleoli. Mitotic figure, cells in prophase (arrow). HE staining. Magnification 1,000x

Following the diagnosis, thoracic radiographs were obtained, along with postoperative ultrasound monitoring, which did not reveal any changes consistent with metastases. Four months post-surgical procedure, the animal exhibited overall well-being, alertness, normal eating habits, and its usual behavior. There was complete reversal of hydronephrosis and hydroureter on ultrasound, and serum biochemistry assessment revealed a return of urea and creatinine levels to within the reference range (44 mg/dL and 0.6 mg/dL, respectively). The animal demonstrated a survival period of two years, maintaining a good quality of life and overall well-being. However, due to an acute and severe presentation of respiratory alterations apparently unrelated to metastases (thoracic radiographs did not show any changes that justified the clinical presentation), the patient deteriorated despite supportive treatment. Consequently, euthanasia was chosen by the owner.

Discussion and conclusions

Hemangiosarcoma is a malignant mesenchymal neoplasm that can be classified into visceral and non-visceral types based on its location [18]. Primary occurrence of this type of tumor in the canine ureter is rare [16, 17], as are other types of tumors in this region [19,20,21,22,23]. In dogs, only two reports describe primary ureteral hemangiosarcoma [16, 17]. In one of the cases, metastases developed shortly after tumor resection [16], differing from the presentation reported here. However, it is important to highlight that due to the acute worsening and respiratory evolution presented by the dog in this report, the possibility of pulmonary thromboembolism, together with metastases that may not have been radiographically identifiable, cannot be ruled out. In any case, despite being a highly metastatic tumor, the timing of metastatic presentations can be variable, as indicated by this and other cases described.

In contrast to previously reported cases [16, 17], the affected dog in this report was male but was of a similar age range. Considering the overall occurrence of visceral hemangiosarcoma in dogs, those over 10 years old are generally more affected [21], aligning with the occurrence of primary ureteral hemangiosarcoma in this case.

The clinical signs presented in this report, including abdominal pain upon palpation, apathy, hematuria, anorexia, and vomiting, although nonspecific, resemble cases of malignant ureteral tumors previously reported, such as leiomyosarcoma [14], sarcoma [22], and urothelial carcinoma [23]. Renal dysfunction secondary to the condition or increased pressure in the renal capsule due to hydronephrosis may explain the observed clinical signs, as well as the presence of the tumor itself, considering that signs usually associated with visceral hemangiosarcoma are also vague and nonspecific [1]. It’s is noteworthy that specific signs of urinary tract involvement, such as hematuria, might not necessarily be present, as observed in the case described by Polit et al. [17].

The prolonged duration of paraplegia and recurrent urinary tract infections observed in the canine patient described here prompts discussion regarding the possibility of a relationship between these comorbidities and neoplastic condition. Although such presentations are not commonly described in veterinary literature, human studies have investigated the link between urinary tract neoplasms, particularly involving the bladder, in patients with spinal cord injuries [24,25,26,27]. The main risk factors in these cases include chronic urinary drainage using catheters, recurrent urinary infections, and a history of urolithiasis [28, 29]. While definitive cause-and-effect relationships cannot be presumed, it is important to consider that paraplegic patients who are chronically managed to maintain urinary flow require increased attention to the occurrence of tumors involving the urinary tract.

In this report, ultrasonographic and contrast radiographic images revealed hydronephrosis and hydroureter affecting the right kidney and ureter, respectively, confirming complete ureteral obstruction in the middle third. This finding differs in location from previous case reports of the same tumor, which indicated tumors in the distal ureter [17] and proximal ureter [16]. According to literature on dogs, the location of the tumor along the ureteral length can be related to the malignancy of the neoplasm, with distal tumors generally being malignant, while proximal tumors tend to be benign [17, 22, 30]. However, although information regarding the location of the ureteral tumor and its malignancy is described, due to the lack of existing evidence, it is not possible to attribute characteristics of malignancy based on tumor location at this time. Just as described here and corroborating with Troiano and Zarelli [16], the occurrence of primary ureteral hemangiosarcoma can affect any portion of the ureteral extension.

According to literature on dogs, the location of the tumor along the ureteral length can be related to the malignancy of the neoplasm, with distal tumors generally being malignant, while proximal tumors tend to be benign [17, 22, 30].

However, as described here and corroborating with Troiano and Zarelli [16], the occurrence of primary ureteral hemangiosarcoma does not adhere strictly to this premise, revealing that any portion of the ureteral extension can be subject to this type of tumor.

Furthermore, this report differs from two others involving the same type of tumor [16, 17] due to its non-invasive local nature, being easily resectable from the ureter and not presenting significant adhesions. This allowed for the preservation of the affected kidney and ureter. The two dogs affected by ureteral hemangiosarcoma previously described had radical surgical approaches as the treatment of choice. In one case, left nephrectomy and ureterectomy were performed, while in the other, left ureteronephrectomy, partial cystectomy were performed [16, 17]. While many factors are involved in the surgical planning for each specific case, the majority of reports involving ureteral neoplasms in dogs resulted in ureterectomy and nephrectomy [13,14,15,16,17, 22, 23], making this the first account in which these noble structures were preserved.

It is essential to emphasize that preserving nephrons should always be the central goal of any surgical therapeutic approach to the urinary tract. This is because, despite imaging changes, it is not possible to estimate the residual functionality of the affected organ. The patient in this report was azotemic before the surgical procedure, indicating that the compensatory capacity of the contralateral kidney was also impaired. The return of urea and creatinine values for this patient to species reference ranges after the procedure reflects the impact on the functional reserve of the previously affected kidney. Similarly, in humans, although upper urinary tract tumors are also rare [31,32,33], it was reported that malignant ureteral tumors can be cured by local resection [34,35,36].

Adding to previously published data [16, 17], where a survival of 40 days and a follow-up of 120 days were reported, the two-year survival along with the quality of life of the dog in this report demonstrates the variety of possible outcomes for this type of presentation. Due to the rarity of primary ureteral hemangiosarcoma in dogs, prognostic information is scarce and precludes any determinations regarding our results or predictions of outcomes.

Based on the data described here, it emphasizes the importance of including primary ureteral hemangiosarcoma in the differential diagnoses of obstructive conditions in the ureter of dogs, whether are associated with clinical signs of the urinary tract or metastases or not.

A possible association in dogs with spinal cord injuries is unclear. Preservation of affected urinary tract structures should be prioritized, especially when possible contralateral renal dysfunction is ongoing. Prognoses cannot yet be definitively determined due to the rarity of this tumor type.

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

EP:

Epithelium

SM:

Submucosa

HE:

Hematoxylin and Eosin

References

  1. Mullin C, Clifford CA. Histiocytic Sarcoma and Hemangiosarcoma Update. Veterinary Clin North America: Small Anim Pract. 2019;49(5):855–79.

    Article  Google Scholar 

  2. Griffin MA, Culp WTN, Rebhun RB. Canine and feline haemangiosarcoma. Vet Rec. 2021;189(9):585.

    Article  Google Scholar 

  3. Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, Couto CG. Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med. 1994;8(5):345–8.

    Article  CAS  PubMed  Google Scholar 

  4. Ware WA, Hopper DL. Cardiac tumors in dogs: 1982–1995. J Vet Intern Med. 1999;13(2):95–103.

    Article  CAS  PubMed  Google Scholar 

  5. Mullin C, Clifford CA. Miscellaneous tumours: Hemangiosarcoma. In: Withrow SJ, Vail DM, Pag RL, editors. Withrow and MacEwen’s Small Animal Clinical Oncology. 5th ed. St. Louis, MO, USA: Elsevier Saunders; 2020. pp. 773–8.

    Google Scholar 

  6. Liptak JM, Dernell WS, Ehrhart EJ, Rizzo SA, Rooney MB, Withrow SJ. Retroperitoneal sarcomas in dogs: 14 cases (1992– 2002). J Am Vet Med Assoc. 2004;224(9):1471–7.

    Article  PubMed  Google Scholar 

  7. Liptak J, Dernell W, Withrow S. Haemangiosarcoma of the urinary bladder in a dog. Aust Vet J. 2004;82(4):215–7.

    Article  CAS  PubMed  Google Scholar 

  8. Townsend S, Regier PJ, More SN. Successful treatment of urinary bladder hemangiosarcoma by partial cystectomy in a dog. J Am Anim Hosp Assoc. 2020;56(4):231–5.

    Article  PubMed  Google Scholar 

  9. Meuten DJ, Meuten TLK. Tumors of the urinary system. In: Meuten DJ, editor. Tumors in domestic animals. Hoboken, New Jersey: Wiley-Blackwell; 2016. pp. 632–88.

    Chapter  Google Scholar 

  10. Hattel AL, Diters RW, Snavely DA. Ureteral fibropapilloma in a dog. J Am Vet Med Assoc. 1986;188(8):873.

    CAS  PubMed  Google Scholar 

  11. Matsumura K, Hosokawa A, Itoh D, Chino J, Sugita Y. Unilateral ureteral obstruction caused by Transitional Cell Papilloma in a dog. J Japan Veterinary Med Association. 2020;73(8):457–61.

    Article  Google Scholar 

  12. Etzioni AL, Raskin RE, Van Alstine WG, Yu J. The cytologic and histologic diagnosis of ureteral fibroepithelial polyp in a dog. Vet Clin Pathol. 2020;49:646–51.

    Article  PubMed  Google Scholar 

  13. Berzon JL. Primary leiomyosarcoma of the ureter in a dog. J Am Vet Med Assoc. 1979;175:374–6.

    CAS  PubMed  Google Scholar 

  14. Yap F, Huizing X, Rasotto R, Bowlt-Blacklock K. Primary ureteral leiomyosarcoma in a dog. Aust Vet J. 2017;95:68–71.

    Article  CAS  PubMed  Google Scholar 

  15. Hanika C, Rebar AH. Ureteral Transitional Cell Carcinoma in the dog. Vet Pathol. 1980;17(5):643–6.

    Article  CAS  PubMed  Google Scholar 

  16. Troiano D, Zarelli M. Multimodality imaging of primary ureteral hemangiosarcoma with thoracic metastasis in an adult dog. Vet Radiol Ultrasound. 2019;60(4):38–41.

    Article  Google Scholar 

  17. Polit JA, Moore EV, Epperson E. Primary Ureteral Hemangiosarcoma in a dog. BMC Vet Res. 2020;16:386.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. De Nardi AB, de Gomes OMS, Fonseca-Alves C, de Paiva CE, Linhares FN, Carra LCM, Cancers, et al. (Basel). 2023;15(7):2025.

    Article  Google Scholar 

  19. Rigas JD, Smith TJ, Elena Gorman M, Valentine BA, Simpson JM, Seguin B. Primary ureteral giant cell sarcoma in a Pomeranian. Vet Clin Pathol. 2021;41:141–6.

    Article  Google Scholar 

  20. Guilherme S, Polton G, Bray J, Blunden A, Corzo N. Ureteral spindle cell sarcoma in a dog. J Small Anim Pract. 2007;48:702–4.

    Article  CAS  PubMed  Google Scholar 

  21. Schultheiss PC. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest. 2004;16(6):522–6.

    Article  PubMed  Google Scholar 

  22. Deschamps JY, Roux FA, Fantinato M, Albaric O. Ureteral sarcoma in a dog. J Small Anim Pract. 2007;48(12):699–701.

    Article  PubMed  Google Scholar 

  23. Kim MY, Aerin J, Traslavina RP, Yoon HY. Orthotopic ureterocele with concurrent ureteral urothelial carcinoma in a dog. Vet Med Sci. 2022;8(5):1881–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology. 2002;59(2):240–4.

    Article  PubMed  Google Scholar 

  25. Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord. 2017;55(4):341–5.

    Article  CAS  PubMed  Google Scholar 

  26. Böthig R, Kurze I, Fiebag K, Kaufmann A, Schöps W, Kadhum T, et al. Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre. Int Urol Nephrol. 2017;49:983–94.

    Article  PubMed  Google Scholar 

  27. Böthig R, Tiburtius C, Schöps W, Zellner M, Balzer O, Kowald B, et al. Urinary bladder cancer as a late sequela of traumatic spinal cord injury. Mil Med Res. 2021;8(1):29.

    PubMed  PubMed Central  Google Scholar 

  28. Stonehill WH, Dmochowski RR, Patterson AL, Cox CE. Risk factors for bladder tumors in spinal cord injury patients. J Urol. 1996;155(4):1248–50.

    Article  CAS  PubMed  Google Scholar 

  29. West DA, Cummings JM, Longo WE, Virgo KS, Johnson FE, Parra RO. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology. 1999;53(2):292–7.

    Article  CAS  PubMed  Google Scholar 

  30. Reichle JK, Peterson RA, Mahaffey MB, Schelling CG, Barthez PY. Ureteral fibroepithelial polyps in four dogs. Vet Radiol Ultrasound. 2003;44(4):433–7.

    Article  PubMed  Google Scholar 

  31. Morinaga S, Aoki S, Tobiume M, Nishikawa G, Muramatsu H, Tsuzuki T, et al. Primary leiomyoma of the ureter: a case report. J Med Case Rep. 2021;15(1):423.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wen S-C, Shen J-T, Jang M-Y, Tsai K-B, Chang S-F, Tsai L-J, et al. Lymphoepithelioma-like carcinoma of ureter—A rare case report and review of the literature. Kaohsiung J Med Sci. 2023;28:509–13.

    Article  CAS  Google Scholar 

  33. Aboutaleb HA, Khurana P, El-Shahat YM. Primary leiomyosarcoma of the middle ureter: a rare case report with literature review. Clin Case Rep. 2022;10(2):e05409.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bin X, Roy OP, Ghiraldi E, Manglik N, Liang T, Vira M, et al. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours. BJU Int. 2012;110:514–9.

    Article  Google Scholar 

  35. Yuan P, Li X, Yuan Y, Xu P, Wang H. Successful kidney-sparing systemic therapy for a high-risk Ureteral Carcinoma Case. Urol Int. 2023;107(9):895–8.

    Article  CAS  PubMed  Google Scholar 

  36. Jia Z, Gong YQ, Zhang CJ, Bao ZQ, Li XS, Hao H, et al. Segmental ureterectomy can be performed safely in patients with urothelial carcinoma of distal ureter. Can Urol Assoc J. 2019;13(7):202–9.

    Google Scholar 

Download references

Acknowledgements

We thank Dr. Vanessa Martins Fayad Milken for providing the radiographic description for one of the images in this study. Her expertise and attention to detail enhanced the quality of our research.

Funding

No external funding was secured for this case report.

Author information

Authors and Affiliations

Authors

Contributions

SM conceived, designed, acquired data, and was involved in the writing, review, and editing of the work. MM performed the conceptualization and the acquisition of the work. LS performed the design, writing and the review of the work. YA performed the writing and the review of the work. AA performed the writing and the review of the work. LC performed the conceptualization, design, acquisition, writing, review and editing of the work. Furthermore, the approval of the submission.

Corresponding author

Correspondence to Suellen Rodrigues Maia.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maia, S.R., Manochio, M., Soares, L.V. et al. Right-sided ureteral hemangiosarcoma in a paraplegic dog. BMC Vet Res 20, 271 (2024). https://doi.org/10.1186/s12917-024-04114-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12917-024-04114-8

Keywords